Statistically significant reductions in all-cause mortality, progression to myelofibrosis, and venous thromboembolism (VTE) occurred among patients with polycythemia vera (PV) who received glucagon-like peptide-1 receptor agonists (GLP-1a), according to data from a propensity-matched analysis presented at the Additionally, the use of GLP-1a conferred a low incidence of hospitalization, intensive care unit (ICU) admission, acute kidney injury (AKI), and ischemic stroke or transient ischemic attack (TIA) in this patient population
Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, Gonzalez JG, Chan M, et al
The dose is then increased in 0.25 mg increments every four weeks until reaching a maintenance dose of 2.4 mg per week It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider to ensure the safe and effective use of these medications
In Part 2, we will cover how we use glutathione at the BioDesign Wellness Center in many of our treatments for a wide range of health conditions
Additionally, all of the metabolic improvements while on the medication were also reversed